Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Infloran® for Prevention of Necrotizing Enterocolitis

View source ↗

Summary

A completed clinical trial (NCT01751477) sponsored by the Medical University of Vienna evaluated Infloran for prevention of necrotizing enterocolitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infloran

Snippet

Sponsor: Medical University of Vienna | Conditions: Necrotizing Enterocolitis | Status: COMPLETED